The Front Room — a clinical regulatory commons
RSS
← Back to feed

CHMP refuses 3 medicines: KemSu, Meplyffa, Qezzaqar

Drug
KemSu, Meplyffa, Qezzaqar
Indication
multiple — see source for per-drug detail

EMA's CHMP issued negative opinions for 3 applications at its 20-23 July 2026 meeting.

Read original at ema.europa.eu

From the source

CHMP plenary 20-23 July 2026. Auto-extracted from the EMA highlights page. Drugs in this dispatch: KemSu Meplyffa Qezzaqar

Reproduced from EMA CHMP Meeting Highlights · view original · public domain or open-licensed government work

Topic regulatory action